Efficacy and safety of dostarlimab plus chemotherapy in patients with endometrial cancer by age category in part 1 of the ruby trial

Atıf İçin Kopyala

Gold M., Bolling M. F., Sharma S., Kommoss S., Gilbert L., Ring K., ...Daha Fazla

INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, sa.SUPPL_3, 2024 (SCI-Expanded)

• Yayın Türü: Makale / Özet
• Basım Tarihi: 2024
• Doi Numarası: 10.1136/ijgc-2024-igcs.15
• Dergi Adı: INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
• Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Biotechnology Research Abstracts, CAB Abstracts, EMBASE, MEDLINE
• Hacettepe Üniversitesi Adresli: Evet